Z-1650-2026 Class II Ongoing

Recalled by Medline Industries, LP — Northfield, IL

FDA device recall Z-1650-2026 was initiated by Medline Industries, LP on Feb 10, 2026 and is designated Class II. Reason for recall: Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects such as… The recall status is ongoing. Affected quantity: 106,621 US; 2,350 OUS.

Recall details

Product Type
Devices
Report Date
Apr 1, 2026
Initiation Date
Feb 10, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
106,621 US; 2,350 OUS

Product description

Puracol and Puracol Plus Collagen Wound Dressings: MSC8522 DRESSING,COLLAGEN,PURACOL,STRL,2" X 2" MSC8622EP DRESSING,COLLAGEN,PURACOL PLUS, 2X2.2"

Reason for recall

Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects such as fever and hypotension. In severe cases, septic shock may result.

Distribution pattern

Domestic distribution nationwide US. International distribution to Mexico and Panama.

Code information

MSC8522 - Puracol UDI-DI 10080196285860 (each) 40080196285861 (case) Lot P2090 MSC8622EP - Puracol Plus UDI-DI 10080196296804 (each) 40080196296805 (case) Lot PL2107

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1650-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1650-2026. Report a data issue: hello@regdatalab.com.